{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:53:00Z","timestamp":1789638780398,"version":"4.0.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Norwegian Institute of Public Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2019.11.054","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T18:23:05Z","timestamp":1576261385000},"page":"3501-3507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The burden of herpes zoster disease in Norway"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-3328","authenticated-orcid":false,"given":"Grazina","family":"Mirinaviciute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else","family":"Quist-Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne Broch","family":"Brants\u00e6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Flem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.054_b0005","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2019.11.054_b0010","article-title":"Postherpetic neuralgia","author":"Watson","year":"2010","journal-title":"Clin Evid"},{"issue":"5","key":"10.1016\/j.vaccine.2019.11.054_b0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","article-title":"Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database","volume":"19","author":"Opstelten","year":"2002","journal-title":"Fam Pract"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.054_b0020","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vaccine.2019.11.054_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system \u2013 prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2019.11.054_b0030","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.052","article-title":"Varicella zoster virus: a common cause of stroke in children and adults","volume":"25","author":"Amlie-Lefond","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.vaccine.2019.11.054_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2019.11.054_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"6 Suppl 2","key":"10.1016\/j.vaccine.2019.11.054_b0045","first-page":"S13","article-title":"Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence","volume":"109","author":"Oxman","year":"2009","journal-title":"J Am Osteopath Assoc"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2019.11.054_b0050","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiy403","article-title":"Immunobiology of varicella-zoster virus infection","volume":"218","author":"Laing","year":"2018","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.11.054_b0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","article-title":"Herpes zoster in the older adult","volume":"31","author":"John","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.vaccine.2019.11.054_b0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2019.11.054_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12889-015-1514-y","article-title":"The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review","volume":"15","author":"Gater","year":"2015","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2019.11.054_b0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.054_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1369-6","article-title":"Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality","volume":"16","author":"Schmidt","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.054_b0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2013predominance in the elderly and in women - a register based study","volume":"13","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.054_b0085","unstructured":"United Nations DESA. Population division. World population prospects: the 2015 revision, key findings and advance tables; 2015."},{"key":"10.1016\/j.vaccine.2019.11.054_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-016-0355-0","article-title":"Real-world effectiveness and safety of a live-attenuated herpes zoster vaccine: a comprehensive review","author":"Ansaldi","year":"2016","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2019.11.054_b0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.11.054_b0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.11.054_b0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-016-1581-4","article-title":"Varicella-zoster virus susceptibility and primary healthcare consultations in Norway","volume":"16","author":"Rimseliene","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.054_b0110","unstructured":"Norway S. Population in Norway; 2018 [cited 2018]. Available from: https:\/\/www.ssb.no\/."},{"key":"10.1016\/j.vaccine.2019.11.054_b0115","unstructured":"Norway, S. 2016, SSB: Oslo."},{"key":"10.1016\/j.vaccine.2019.11.054_b0120","series-title":"Age standartization of rates: a new WHO standard","author":"Ahmad","year":"2001"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.054_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","article-title":"Gender difference in the incidence of shingles","volume":"132","author":"Fleming","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2019.11.054_b0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2188\/jea.JE20140210","article-title":"Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study","volume":"25","author":"Takao","year":"2015","journal-title":"J Epidemiol"},{"issue":"18","key":"10.1016\/j.vaccine.2019.11.054_b0135","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2019.11.054_b0140","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2019.11.054_b0145","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","article-title":"Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination","volume":"25","author":"Di Legami","year":"2007","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2019.11.054_b0150","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: burden of disease in France","volume":"28","author":"Gonzalez Chiappe","year":"2010","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2019.11.054_b0155","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.16.20147-en","article-title":"The Norwegian immunisation register\u2013SYSVAK","volume":"17","author":"Trogstad","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.11.054_b0160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12889-015-1753-y","article-title":"Herpes zoster-associated mortality in Europe: a systematic review","volume":"15","author":"Bricout","year":"2015","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.vaccine.2019.11.054_b0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4045\/tidsskr.14.1065","article-title":"Data quality in the causes of death registry","volume":"135","author":"Pedersen","year":"2015","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.vaccine.2019.11.054_b0170","article-title":"General practitioners' use of ICPC diagnoses and their correspondence with patient record notes","author":"Sporaland","year":"2019","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.054_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4045\/tidsskr.13.1417","article-title":"The Norwegian patient register\u2013an important source for research","volume":"134","author":"Bakken","year":"2014","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"8","key":"10.1016\/j.vaccine.2019.11.054_b0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00006454-199108000-00004","article-title":"Recurrent varicella-zoster virus infections in apparently immunocompetent children","volume":"10","author":"Junker","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.11.054_b0185","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1542\/peds.2013-4037","article-title":"Epidemiology of pediatric herpes zoster after varicella infection: a population-based study","volume":"135","author":"Wen","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.054_b0190","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003\u20132014","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.11.054_b0195","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001656","article-title":"Varicella-related primary healthcare visits, hospitalizations and mortality in Norway, 2008\u20132014","author":"Mirinaviciute","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.054_b0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/jir239","article-title":"Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study","volume":"204","author":"Kang","year":"2011","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2019.11.054_b0205","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.vaccine.2019.11.054_b0210","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.vaccine.2018.01.038","article-title":"Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway","volume":"36","author":"Marchetti","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:01Z","timestamp":1759401721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X19315968"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of herpes zoster disease in Norway","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}